The three disease-modifying therapies for MS added into the World Health Organization’s (WHO) Essential Medicines list is a great step forward for patients afflicted with this chronic disease and could also serve as a model for other neurological disorders. Dive in as Dr. Charles Turck talks to one member of the team who was responsible for submitting this list of medications, Dr. Jay Avasarala, Director of Comprehensive Care Center for Multiple Sclerosis and Neuroimmunology at the Kentucky Neuroscience Institute in Lexington.